Efficacy and safety of Niaoqingshu granules in the treatment of chronic pelvic pain syndrome(syndrome of dampness-heat diffusing downward)

The First Affiliated Hospital of Tianjin University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1) Meet the western diagnostic criteria of non-bacterial CP and TCM syndrome differentiation criteria of dampness-heat syndrome;
•2) 18 to 50 years old;
•3) The course of disease is not less than 3 months;
•4) No prostatitis drugs were used in nearly 2 weeks before inclusion;
•5) Informed consent, voluntary subjects;
•6) The process of obtaining informed consent conforms to the drug clinical trial Management Code (GCP).

•? Renal function and liver function indexes are above 50% of the upper limit of normal value;
•? Patients with serious primary diseases, including lung diseases, hematological diseases and cardiovascular diseases, or AIDS and tumors;
•? Have a history of pelvic surgery, severe neurosis, seminal vesiculitis, prostate tumor, benign prostatic hyperplasia, epididymitis, urinary tract diseases and diabetes, etc.
•(4) mentally ill or disabled;
•? Allergic to the test drug or allergic constitution;
•? By non-prostatitis caused by lumbosacral, perineum and lower abdomen and other painful diseases;
•? Bacterial CP and acute prostatitis;
•(8) those who have or are suspected of drug or alcohol abuse;
•? Applicants who are participating in other clinical trials.

发起方

The First Affiliated Hospital of Tianjin University of Chinese Medicine